Clinical Trial

Non-invasive Phrenic Nerve Stimulation in ARDS Patient

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 27, 2024 (before its estimated December 30, 2024 completion). Its status may not reflect the trial's current state.
Summary
Reduced diaphragmatic activity during mechanical ventilation can lead to diaphragmatic disuse atrophy, atelectasis, increased lung stress and strain, and hemodynamic impairment. This, in turn, may prolong the duration of mechanical ventilation, make weaning more difficult, and even increase mortality. Synchronizing phrenic nerve stimulation to promote diaphragmatic activity may prevent ventilator-induced lung injury and ventilator-induced diaphragm dysfunction, thereby improving patient outcomes. Surgically implanted phrenic nerve stimulation has been used in certain neurological disorders, but the effects of percutaneous non-invasive synchronized phrenic nerve stimulation in patients with ARDS undergoing mechanical ventilation remain unclear and require further investigation.
Trial Details
NCT Number NCT06572280
Lead Sponsor Southeast University, China
Conditions ARDS, Human, Ventilator-Induced Lung Injury, Diaphragm Injury
Enrollment 10 participants
Start Date 2024-08-01
Primary Completion 2024-12-30 (estimated)
Study Completion 2025-01-30 (estimated)
Updated on ClinicalTrials.gov 2024-08-27